Home 2021 Politicizing Medicine has Deadly Consequences

Politicizing Medicine has Deadly Consequences

by Paul Ebeling

#COVID19 #treatment #HCQ #zinc #hospitalization #death

The American Journal of Medicine in its January 2021 issue now urges early use of HCQ and Zinc to reduce hospitalizations and deaths from COVID-19 noting the following:

  • Early on in the COVID-19 chaos, doctors around the world reported high success rates using an inexpensive treatment protocol of HCQ (hydroxychloroquine) and zinc in combination with an antibiotic to treat secondary bacterial infections
  • HCQ is a zinc ionophore, meaning it shuttles zinc into the cell, and there is compelling evidence that suggest the primary benefit of the HCQ protocol actually comes from the zinc, which effectively inhibits viral replication
  • For patients with cardinal features of COVID-19: fever, body aches, nasal congestion, loss of taste and smell at-home treatment can be the same as those with confirmed COVID-19, the authors say
  • While MSM headlines have painted HCQ as a life-threatening drug, it actually has a very robust safety profile that goes back decades.

The graphic below from The American Journal of Medicine illustrates the different approaches to home care suggested depending on whether you are healthy, have a single comorbidity or several, and at which point in the disease process the various drugs should be administered.

The Big Q: Did Dr. Anthony Fauci, appointed to lead President Trump’s White House Pandemic Response Team, know about this?

The Big A: If he did, why didn’t he say something?

Have a healthy week, Keep the Faith!

You may also like


Your Trusted Source for Capital Markets & Related News

© 2024 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.